<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Foxp3(+) T regulatory cells (Tregs) and Th17 cells accumulate synchronously at <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sites during <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e>, where their interplay is apparently affecting the efficiency of the antitumor response </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, a <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancy</z:e> of myeloid origin, Tregs are highly increased in the late stages of the disease (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), but the mechanisms driving Treg expansion and the interaction between Treg and Th17 cell dynamics are still unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We demonstrate that the proliferative capacity of Tregs is deficient during the early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stages (E-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), while in L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> it returns to <z:mpath ids='MPATH_458'>normal</z:mpath> levels </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, synchronously to Treg expansion, L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients exhibit increased numbers of functionally competent bone marrow IL-17(+) and FOXP3(+)/IL-17(+) cells, in contrast to E-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, where Th17 cells are significantly decreased and hypofunctional </plain></SENT>
<SENT sid="4" pm="."><plain>Our findings suggest similar kinetics of Treg and Th17 cells between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, indicating a common immune pathogenetic pathway between diverse <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
</text></document>